Klebsiella ESBL bacteremia-mortality and risk factors
Tuon, Felipe Francisco, Kruger, Margot, Terreri, Marcos, Penteado-Filho, Sergio R, Gortz, Lucas
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
Background: Extended spectrum β-lactamase (ESBL)-producing bacteria have become recognized as a problem in South America. The aim of this study was to evaluate risk factors and mortality rate in bacteremia caused by ESBL-producing Klebsiella pneumoniae in a Brazilian hospital. Methods: A three-year retrospective cohort study with 104 cases of K. pneumoniae bacteremia (61 ESBL and 43 non-ESBL). Several clinical and laboratory variables were evaluated. The outcome of interest was 30-day mortality. The adequate treatment was evaluated according to antibiotic susceptibility. Results: Multivariable analysis showed that central venous catheter and mechanical ventilation were independent risk factors for ESBL. The duration of hospitalization before the bacteremia was not a risk factor. Mortality was similar in ESBL and non-ESBL and inadequate therapy was not shown to be a risk factor. Conclusion: ESBL-producing Klebsiella bacteremia can occur early, suggesting that a carbapenem should be included in the initial empirical therapy for bacteremia in patients under mechanical ventilation and/or central venous catheter in our institution.
- Risk factors for mortality in Acinetobacter bacteremia
- Risk factors for KPC-producing Klebsiella pneumoniae bacteremia
- Is nosocomial Escherichia coli bacteremia a predictive risk factor for mortality?
- Bloodstream infections caused by ESBL-producing E. Coli and K. pneumoniae: risk factors for multidrug-resistance
- Estimating risk factors for acinetobacter bacteremia in pediatric settings